Next Article in Journal
The Role of LIM Kinases during Development: A Lens to Get a Glimpse of Their Implication in Pathologies
Next Article in Special Issue
Functional Role of microRNAs in Regulating Cardiomyocyte Death
Previous Article in Journal
Reproductive Toxicity of Furfural Acetone in Meloidogyne incognita and Caenorhabditis elegans
Previous Article in Special Issue
Tfeb-Mediated Transcriptional Regulation of Autophagy Induces Autosis during Ischemia/Reperfusion in the Heart
Review

Novel Techniques Targeting Fibroblasts after Ischemic Heart Injury

Department of Physiology, The Brody School of Medicine, East Carolina University, Greenville, NC 27834, USA
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Academic Editor: Dominic P. Del Re
Cells 2022, 11(3), 402; https://doi.org/10.3390/cells11030402
Received: 10 December 2021 / Revised: 21 January 2022 / Accepted: 23 January 2022 / Published: 25 January 2022
(This article belongs to the Special Issue Mechanisms of Ischemic Heart Injury)
The great plasticity of cardiac fibroblasts allows them to respond quickly to myocardial injury and to contribute to the subsequent cardiac remodeling. Being the most abundant cell type (in numbers) in the heart, and a key participant in the several phases of tissue healing, the cardiac fibroblast is an excellent target for treating cardiac diseases. The development of cardiac fibroblast-specific approaches have, however, been difficult due to the lack of cellular specific markers. The development of genetic lineage tracing tools and Cre-recombinant transgenics has led to a huge acceleration in cardiac fibroblast research. Additionally, the use of novel targeted delivery approaches like nanoparticles and modified adenoviruses, has allowed researchers to define the developmental origin of cardiac fibroblasts, elucidate their differentiation pathways, and functional mechanisms in cardiac injury and disease. In this review, we will first characterize the roles of fibroblasts in the different stages of cardiac repair and then examine novel techniques targeting fibroblasts post-ischemic heart injury. View Full-Text
Keywords: cardiac fibroblast; myocardium; novel delivery methods; nanoparticles; fibroblast-specific cardiac fibroblast; myocardium; novel delivery methods; nanoparticles; fibroblast-specific
Show Figures

Figure 1

MDPI and ACS Style

Cakir, S.N.; Whitehead, K.M.; Hendricks, H.K.L.; de Castro Brás, L.E. Novel Techniques Targeting Fibroblasts after Ischemic Heart Injury. Cells 2022, 11, 402. https://doi.org/10.3390/cells11030402

AMA Style

Cakir SN, Whitehead KM, Hendricks HKL, de Castro Brás LE. Novel Techniques Targeting Fibroblasts after Ischemic Heart Injury. Cells. 2022; 11(3):402. https://doi.org/10.3390/cells11030402

Chicago/Turabian Style

Cakir, Sirin N., Kaitlin M. Whitehead, Hanifah K.L. Hendricks, and Lisandra E. de Castro Brás. 2022. "Novel Techniques Targeting Fibroblasts after Ischemic Heart Injury" Cells 11, no. 3: 402. https://doi.org/10.3390/cells11030402

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop